ArticleBMJ open2025
Determinants of 30-day readmissions in adult patients with heart failure in Pakistan: a prospective cohort study protocol.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHeart failure (HF) is a prevalent cardiovascular disease worldwide, affecting 1-2% of adults. According to the WHO 2022 report, Pakistan ranks 18th globally for HF-related deaths. The exact prevalence of HF is not well documented. Additionally, knowledge and self-care behaviour among patients with HF are suboptimal. Therefore, this study aims to assess the knowledge and self-care behaviours of patients with HF before being discharged from the hospital and tracks the time to 30-day readmissions. METHODS AND ANALYSIS: A prospective cohort research design will be used. Patients will be recruited from three tertiary care hospitals through consecutive sampling based on specific inclusion criteria. A structured tool will be used to collect demographic and clinical variables from 227 patients with HF. The Urdu version of the knowledge and self-care behaviour questionnaires will be used to collect the data. Kaplan-Meier product limit method and Cox proportional hazards model will be employed to obtain estimates with 95% CIs. ETHICS AND DISSEMINATION: The study has been approved by the Institutional Review Board (IRB) of Shifa Tameer-e-Millat University, Pakistan (IRB 103-24), and written permission was obtained from the administration of the understudy hospitals. Before obtaining a written consent, all patients will receive detailed information about the study. Patients will have the freedom to withdraw from the study at any point. Patients' confidentiality will be ensured. The study findings will be disseminated to essential stakeholders and published in scientific papers and conference proceedings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.